BOSTON — This is an official press release from the U.S. Department of Justice (USAO - Massachusetts), published as received.
BOSTON – A former traveling nurse was sentenced today in federal court in Boston for tampering with morphine at a local rehabilitation facility.
Loralie LaBroad, 55, of Hampton, N.H., was sentenced by U.S. District Judge Julia E. Kobick to three months in prison, to be followed by two years of supervised release during which she is prohibited from practicing as a registered nurse or any other work with access to prescription medication or other controlled substances. In November 2024, LaBroad pleaded guilty to one count of tampering with a consumer product. LaBroad was charged by an Information in September 2024.
LaBroad worked as a registered nurse for over 30 years, licensed in both New Hampshire and Massachusetts. In 2021, LaBroad voluntarily surrendered her New Hampshire nursing license following an investigation by the New Hampshire Board of Nursing after being fired from a rehabilitation center in Derry, N.H. as a result of allegations that she had tampered with morphine bottles.
After surrendering her New Hampshire license, LaBroad continued to practice under her Massachusetts license. From December 2021 through at least May 12, 2022, LaBroad was employed as a traveling nurse through a healthcare staffing company and was assigned to various nursing and rehabilitation facilities throughout Massachusetts. Several of these Massachusetts facilities also began to suspect that LaBroad was diverting morphine from patients because of her consistent access to the bottles of morphine and evidence of tampering (i.e. bottles that were leaking or appearing to be the wrong color). Several of these bottles were tested and came back at significantly diluted concentrations.
In the spring of 2022, LaBroad was assigned to work at a nursing and rehabilitation center in Danvers. LaBroad had access to morphine because she was charged with treating multiple patients who had been prescribed morphine for relief of their pain. In April 2022, the rehabilitation center contacted law enforcement after a nurse noticed a bottle of morphine was wet and leaking. Administrators at the facility reviewed other bottles of morphine on other medicine carts and identified three additional bottles that appeared to have been tampered with because the color of the bottle was lighter than expected or the bottle had puncture holes in the seal. Laboratory tests confirmed all bottles were diluted to varying degrees. LaBroad had been assigned to the medicine carts containing these bottles of morphine approximately two days before they were discovered.
Following these suspected incidents of tampering, law enforcement undertook a “controlled operation” to determine whether LaBroad was tampering with the bottles of morphine. On May 12, 2022, prior to LaBroad’s next shift, law enforcement worked with the Danvers rehabilitation center administrators to review and photograph the bottles of morphine on the cart to be assigned to LaBroad. The cart included two bottles of morphine assigned to the same patient – one of which was fully sealed before LaBroad’s shift and the other was opened, from which investigators took a control sample. LaBroad was the only individual with access to the medicine cart for the duration of her shift.
At the end of LaBroad’s shift, law enforcement seized the two bottles of morphine before they could be dispensed to the assigned patient. It was discovered that the previously sealed bottle was a different color, leaking and showed evidence of multiple puncture holes. Laboratory testing results confirmed that both bottles of morphine had been tampered with and diluted.
United States Attorney Leah B. Foley; Fernando McMillan, Special Agent in Charge of the Food and Drug Administration, Office of Criminal Investigations; Roberto Coviello, Special Agent in Charge of the Department of Health and Human Services, Office of the Inspector General; and Robert H. Goldstein, MD, PhD, Commissioner of the Massachusetts Department of Public Health made the announcement. Assistant U.S. Attorney Lauren A. Graber of the Criminal Division prosecuted the case.
